Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma [Phase 2]
Phase 2 trial evaluating pazopanib in combination with paclitaxel as first-line therapy for unresectable Stage III and Stage IV melanoma; re…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma
This clinical trial update summarizes the utilization, effectiveness, and safety of ipilimumab in a PAN-European Expanded Access Program for…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII [Phase 2]
Phase 2 clinical trial update evaluating GEN0101 in combination with pembrolizumab for advanced melanoma. The current status of the trial is…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS
A clinical trial update on the acceptability and frequency of writing advanced directives among onco-dermatology patients.
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study evaluating low-dose adjuvant ipilimumab plus nivolumab after surgical resection of melanoma macr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])
This update describes a study of cobimetinib (Cotellic) in adults with BRAF V600 mutation–positive advanced melanoma under the French TAU pr…
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
This update reports a Phase 2 trial testing ipilimumab with or without high-dose recombinant interferon alfa-2b in patients with unresectabl…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma [Phase 3]
A Phase 3 trial assessing multiple administration regimens of nivolumab plus ipilimumab in melanoma has completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054) [Phase 3]
Phase 3 trial evaluating pembrolizumab after complete resection of high-risk stage III melanoma; results posted for MK-3475-054/1325-MG/KEYN…
-
CLINICAL_TRIALS trial_result · 2018-12-28Clinical Trial Update: Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma [Phase 1, Phase 2]
A Phase I/II trial evaluating high-dose calcitriol in combination with temodar for metastatic melanoma has completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Phase 1, Phase 2]
A pediatric Phase 1/2 study assessed the safety and early activity of weekly nab-paclitaxel in children with recurrent or refractory solid t…
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma [Phase 1]
Phase 1 trial of NY-ESO-1 vaccine combined with ipilimumab in unresectable or metastatic melanoma was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma [Phase 2]
Phase 2 trial investigating the immunological effects of vemurafenib plus cobimetinib in patients with melanoma has been terminated with res…
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating individualized temozolomide in patients with unresectable Stage IV melanoma; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Study With T-cel Receptor Gene Therapy in Metastatic Melanoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating a T-cell receptor gene therapy for metastatic melanoma, including stage IV skin melanoma and ocular me…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Recombinant Interferon Alfa-2b in Treating Patients With Melanoma [NA]
Clinical trial update for recombinant interferon alfa-2b in melanoma shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Imatinib Mesylate in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial update evaluating imatinib mesylate in metastatic melanoma; completed study.
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma [Phase 3]
Phase 3 trial of vemurafenib as adjuvant therapy in surgically resected BRAF-mutant melanoma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel [Phase 2]
Phase 2 trial assessing metabolic activity and transcriptional profiling in melanoma patients treated with pazopanib alone or with paclitaxe…
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating carboplatin with ABI-007 (nab-paclitaxel) in stage IV melanoma not amenable to surgery; study completed with result…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). [Phase 3]
Phase 3 COMBI-AD trial update reports results for dabrafenib plus trametinib as adjuvant treatment in high-risk BRAF V600 mutation-positive …
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Treatment of Metastatic Melanoma With Tumor Infiltrating Lymphocytes and IL-2 Following Lympho-depleting Chemotherapy [Phase 2]
Phase 2 trial update evaluating tumor-infiltrating lymphocytes plus IL-2 after lymphodepleting chemotherapy in metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma [Phase 2]
Phase 2 trial evaluating a new anti-cancer treatment in unresectable advanced melanoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer [Phase 1]
Phase 1 trial update for a new vaccine treatment in patients with metastatic melanoma; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating safety and tolerability of cobimetinib plus GDC-0994 in patients with various advanced solid tumors, including no…